A Randomized Controlled Trial Comparing Remission Induction with Modified Multitarget Therapy with Intravenous Cyclophosphamide in Proliferative Lupus Nephritis

INTRODUCTION: Therapy of proliferative lupus nephritis (PLN) is yet to be optimized. Standard of care for induction consists of intravenous (IV) cyclophosphamide (CYC) and steroids, which shows an improved outcome, but end-stage renal disease (ESRD) progression, increased mortality, and therapy-rela...

Descripción completa

Detalles Bibliográficos
Autores principales: Pal, Atanu, Chaudhury, Arpita Ray, Bhunia, Abhirup, Bhattacharya, Koushik, Chatterjee, Suparna, Divyaveer, Smita Subhash, Sircar, Dipankar, Sen, Debabrata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593294/
https://www.ncbi.nlm.nih.gov/pubmed/37881738
http://dx.doi.org/10.4103/ijn.ijn_355_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593294/
https://www.ncbi.nlm.nih.gov/pubmed/37881738
http://dx.doi.org/10.4103/ijn.ijn_355_21

Ejemplares similares